Nigeria’s healthcare sector growing but inadequate on stock exchange – Ugodre
Nigeria’s healthcare sector, though growing steadily, remains significantly inadequate in the broader economy, according to financial analyst and CEO of ...
Nigeria’s healthcare sector, though growing steadily, remains significantly inadequate in the broader economy, according to financial analyst and CEO of ...
A significant factor contributing to the exodus of multinational companies is the declining purchasing power of Nigerian consumers
From tech startups like Lazarpay to multinational giants like GlaxoSmithKline and Procter & Gamble, the exodus was profound, signalling the ...
According to data obtained by Nairametrics from the NGX which focused on best-performing healthcare stocks, these stocks made the list ...
GlaxoSmith Kline Plc released its unaudited financial results for the third quarter of the year ended 30th of September, 2021. ...
The FG has disclosed that UK businesses operating in Nigeria will continue to have the necessary support of the government.
The results also showed that the Company’s Turnover grew by 3% to close at N21.3 billion as against N20.7 billion ...
The results were less than impressive with several key indicators showing a year-on-year decline.
GlaxoSmithKline has expanded the size of its Board of Directors with the appointment of a former director at Lafarge, Oludewa Adodo-Thorpe.
The Board of Directors of GlaxoSmithKline Consumer Nigeria Plc (GSK), has appointed a new Managing Director (MD).